Loading song details...
AGDD 2024 D2S11 ICH M13A First Guideline For Bioequivalence
No description available.
MP3 Download
Video Download
Related Songs
22:02
AGDD 2024 D2S11 ICH M13A First Guideline For Bioequivalence
15:29
AGDD 2024 D1S11 Orally Inhaled Drug Product PSGs Considerations For Using Modeling And Sim
22:53
AGDD 2024 D1S10 Orally Inhaled Drug Product PSGs General Considerations Using The Alternative
16:14
AGDD 2024 D1S02 IVRT Methods For In Situ Depot Forming Long Acting Injectable Products
22:47
AGDD 2024 D1S14 Drug Device Combination Products A New Methodology For Evaluation
12:28
AGDD 2024 D1S15 Approaches To Analyzing Comparative Use Human Factors Studies
21:06
AGDD 2024 D2S09 Guidance For Industry Content And Format Of Composition Statement
22:07
AGDD 2024 D2S06 Emerging Generic Oligonucleotides Challenges And Progress
11:54
AGDD 2024 D2S05 1 Totality Of Evidence Including Physiologically Based Pharmacokinetic Modeling
17:29
AGDD 2024 D1S01 Keynote Address
16:20
GDF 2024 D2S11 2 GDUFA III Implementation Facility Related Updates
5:24
AGDD 2024 D1S16 Closing Remarks From Day One
21:59
AGDD 2024 D2S02 Quality Considerations For First Generic Oral Liquids
13:29
AGDD 2024 D1S03 Nano Size Complex Products In Vitro Release Testing IVRT
15:57
AGDD 2024 D1S04 Application Of Adaptive Perfusion As In Vitro Release Testing Method
29:19
AGDD 2024 D2S07 The Journey Of First Approvals Complex Generic Long Acting Injectable Products
7:07
AGDD 2024 D2S14 Closing Remarks
17:12
AGDD 2024 D1S07 Enhanced Understanding Of Structure Performance Relationship Using Modeling
18:42
AGDD 2024 D1S08 Approaches For Evaluation Of Formulation Differences On Performance Topical
1:56:58